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completion of BAX recruitment 
correlates with mitochondrial 
fission during apoptosis
M. e. Maes1,2, J. A. Grosser1, R. L. fehrman1, C. L. Schlamp1,3 & R. W. nickells1*
BAX, a member of the BCL2 gene family, controls the committed step of the intrinsic apoptotic 
program. Mitochondrial fragmentation is a commonly observed feature of apoptosis, which occurs 
through the process of mitochondrial fission. BAX has consistently been associated with mitochondrial 
fission, yet how BAX participates in the process of mitochondrial fragmentation during apoptosis 
remains to be tested. Time-lapse imaging of BAX recruitment and mitochondrial fragmentation 
demonstrates that rapid mitochondrial fragmentation during apoptosis occurs after the complete 
recruitment of BAX to the mitochondrial outer membrane (MOM). The requirement of a fully 
functioning BAX protein for the fission process was demonstrated further in BAX/BAK-deficient HCT116 
cells expressing a P168A mutant of BAX. The mutant performed fusion to restore the mitochondrial 
network. but was not demonstrably recruited to the MOM after apoptosis induction. Under these 
conditions, mitochondrial fragmentation was blocked. Additionally, we show that loss of the fission 
protein, dynamin-like protein 1 (DRP1), does not temporally affect the initiation time or rate of BAX 
recruitment, but does reduce the final level of BAX recruited to the MOM during the late phase of BAX 
recruitment. These correlative observations suggest a model where late-stage BAX oligomers play a 
functional part of the mitochondrial fragmentation machinery in apoptotic cells.
The BCL2 gene family works cooperatively to initiate and execute the intrinsic apoptotic pathway. BAX, a 
pro-apoptotic family member, is responsible for executing the committed step of the intrinsic apoptotic program1. 
BAX predominantly resides in the cytosol as an inactive monomer, but once activated, undergoes a conforma-
tional change2 that catalyzes dimerization at the mitochondrial outer membrane (MOM)3,4, the site of recruit-
ment5,6, leading to oligomer formation and MOM permeabilization (MOMP)7,8. BAX oligomer formation and 
MOMP facilitate the release of cytochrome c9,10, and are often considered the ‘point of no return’ in the apoptotic 
program11.
One hallmark of apoptosis is mitochondrial fragmentation, which is the product of halted mitochondrial 
fusion and increased mitochondrial fission12–14. Mitochondria are dynamic organelles constantly undergoing fis-
sion and fusion, the process of mitochondrial separation and reconnection, which occurs asynchronously within 
a cell at steady state. The rates of fission and fusion are balanced during the steady-state in order to create an 
equilibrium necessary to each cell’s needs15. Mitochondrial fission is primarily regulated by DRP116, dynamin 2 
(DYN2)17, with the aid of adaptor proteins Fis118, and mitochondrial dynamics proteins 49 and 51 (MiD49/51)19. 
DRP1 is a dynamin-like large GTPase which, like dynamin, will lasso around and constrict mitochondria at the 
point of scission20. Mitochondrial fusion requires separate machinery including OPA121, MFN1 and MFN222. 
Surprisingly, BAX and its homologue BAK, are also essential components of the fusion process in healthy cells 
and are thought to help localize MFNs to sites of fusion through direct binding23–25. During apoptosis, the 
dynamic mitochondrial equilibrium is disrupted as fission predominates and fusion is halted, resulting in wide-
spread mitochondrial fragmentation. Importantly, the switch to apoptosis is controlled by BAX, preventing it 
from participating in fusion14. Steady-state fission and apoptosis-associated fission appear to be governed by 
separable processes, which could then be regulated by different mechanisms26.
The process of BAX recruitment occurs rapidly once initiated, and follows a sigmoid pattern of recruitment, 
which exhibits an early and late phase27,28. The early phase, or initiation of BAX recruitment, includes dimer and 
oligomer formation at the MOM, leading to MOMP and apoptotic molecule release9,10. The late phase, or the 
completion of BAX recruitment, is the point at which the exponential growth of the BAX curve is suspended 
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and reaches a plateau. It has been assumed that the function of the BAX oligomer is to release cytochrome c and 
initiate the downstream caspase cascade, but since the release of cytochrome c and other pro-apoptotic signaling 
molecules occurs during the early recruitment phase28, this provides no explanation for its continued recruitment 
to the MOM, or for the pivotal plateau commencement where BAX recruitment concludes.
One potential function for the completion of BAX recruitment is regulation of mitochondrial fission. Although 
BAX and the mitochondria are consistently associated, the direct relationship between mitochondrial fragmenta-
tion and apoptotic machinery has not been fully described12,29,30. After an apoptotic stimulus, BAX clusters at the 
cardiolipin-rich mitochondrial scission sites16, where it colocalizes with DRP131. Mitochondrial scission creates 
a change in membrane curvature, which has been shown to facilitate integration of membrane-associated pro-
teins32,33, and studies have suggested that DRP1 may stimulate BAX oligomerization34. While these data are critical 
to outline the setting for BAX and fission during apoptosis, it is possible that the recruitment of BAX is an epiphe-
nomenon associated with membrane curvature, DRP1 localization, cardiolipin enrichment at the scission sites, or 
some combination of all these features. Alternatively, other studies have indicated that overexpression of BAX can 
enhance mitochondrial fragmentation after induction of apoptosis, or even spontaneously initiate fragmentation in 
the absence of an inducer12. These latter observations, along with the localization studies showing BAX aggregations 
at scission sites, has strongly implicated the existence of a BAX-dependent role in mitochondrial fragmentation.
Temporally, it has been shown that mitochondrial fragmentation occurs after cytochrome c release, which is 
associated with initial BAX recruitment35, suggesting that MOMP may be mechanistically independent of fission 
during apoptosis30. In studies using the protozoan Trypanosoma brucei, an organism with a single mitochondrion 
and no apoptotic machinery, expression of exogenous BAX induces cytochrome c release, loss of MOM potential, 
and mitochondrial fission, in separable and sequential order36. Here, we show that completion of BAX recruit-
ment is temporally associated with a rapid loss of mitochondrial volume, and that cells expressing a BAX mutant 
retaining its fusion properties but with impaired ability to translocate to the MOM during apoptosis, fail to exhibit 
apoptosis-induced mitochondrial fragmentation. Altering DRP1 function in apoptotic cells has no effect on the 
initiation or rate of BAX recruitment, but does modulate the total level of BAX that is recruited in the plateau 
phase of the process.
Results and Discussion
Completion of BAX recruitment coincides with a period of rapid mitochondrial volume decrease. 
BAX recruitment to the MOM was assessed by time-lapse imaging of live cells expressing fluorescently tagged 
BAX. Once initiated, the recruitment process was complete within 10–20 minutes. Kinetic analysis at individual 
mitochondrial foci showed that recruitment followed a sigmoid curve in all cell types examined, which allowed 
us to mathematically define the times for initiation and completion of the recruitment process (Fig. S1). Detailed 
methods for quantitation of BAX recruitment can be referenced in Maes et al.28. Mitochondria were identified 
using a mito-BFP tag and changes in these organelles were monitored and quantitated in a temporal series of 
Z-stacked images. Three-dimensional objects were rendered from these images using IMARIS 7.7 software, which 
determined the volume of contiguous organelles. For each cell, the average mitochondrial volume of all objects 
was calculated for the duration of the time-lapse images and converted to a heat map. Figure 1 shows a compar-
ison of wild type BAX recruitment and mitochondrial changes in two different cell types undergoing apoptosis. 
Recruited BAX formed characteristic puncta that accumulated at the fission sites of fragmenting mitochondria 
(Fig. 1A,B) as previously described31,37. Heat map representations of mitochondrial volume showed that both cell 
types exhibited a dramatic decrease in the average volume of all mitochondrial objects as they underwent apop-
tosis (Fig. 1C,D, Video 1). Data from individual cells were evaluated for the change in average mitochondrial vol-
ume during the 20 minute interval before the initiation of BAX recruitment (Stage 1), during recruitment (Stage 
2), and 20 minutes after completion of BAX recruitment (Stage 3) (Figs 1E,G, S1). Box and whisker plots show 
the rate of average volume change for each stage. For Stages 1, 2, and 3, respectively, D407 cells showed rates of 
−0.29 ± 0.6 relative mitochondrial volume per minute (RMV/min), 0.73 ± 1.2 RMV/min, and −3.0 ± 1.2 RMV/
min (Fig. 1F), while 661W cells showed rates of −0.19 ± 0.8 RMV/min, −0.50 ± 0.5 RMV/min, and −1.45 ± 0.5 
RMV/min (Fig. 1H). In a separate experiment, the change in mitochondrial volume was assessed in human 
ARPE-19 cells treated with staurosporine (STS). BAX recruitment initiation and termination were determined 
manually in these cells, so these data were not included in Fig. 1. However, a similar pattern of mitochondrial 
volume change was observed in these cells as well (Fig. S2). All cell types showed a significant decrease in aver-
age mitochondrial volume after completion of BAX recruitment (Stage 3) when compared to Stage 1 as base-
line (p < 0.05). Notably, there was no significant difference between Stage 1 and 2 rates in each cell type (D407 
p = 0.28, 661W p = 0.45, ARPE-19 p = 0.06). These data show that completion of BAX recruitment identifies the 
point of rapid mitochondrial volume changes within an apoptotic cell.
MOMP and fission have previously been shown to be separate events both temporally35,38 and mechanisti-
cally30. In MOMP, cytochrome c may be released, theoretically, through a pore induced by a single BAX mole-
cule39, or more likely from a single BAX dimer8. Kinetic analysis of mCherry-BAX recruitment and cytochrome 
c-GFP or SMAC/Diablo-GFP release in D407 cells indicates that MOMP is rapidly induced and essentially com-
plete very early in the process of BAX recruitment and well in advance of mitochondrial fragmentation in these 
cells28. Others have demonstrated that BAX monomers are rapidly integrated into dimers and then oligomers 
once the process of recruitment is initiated8,40. While continued growth of the oligomer may function to increase 
pore size, allowing for the release of larger molecules8,40, the correlation between the end of BAX recruitment and 
the onset of mitochondrial fission further supports a mechanistic role of the BAX oligomer in the fission process.
BAX is essential for apoptosis-induced mitochondrial fission. The requirement for BAX in mito-
chondrial fission has been inferred by its localization to scission sites, its relationship with DRP1, and observa-
tions that overexpression of exogenous BAX can lead to spontaneous fragmentation12,29. The ability to accelerate 
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Figure 1. BAX recruitment completion coincides with rapid decline in mitochondrial volume. Mitochondrial 
fission occurs at the site of BAX recruitment. Images from a time-lapse video show recruited wild type 
mCherry-BAX at isolated mitochondria (mito-BFP, pseudo-colored teal) as the fission process completes 
in (A) a D407 cell and (B) a 661W cell. In these time series, the first and last image depicts a representative 
timepoint before and after fission, while the remaining images demonstrate the consecutive timeframes as the 
mitochondria are separating. Mitochondrial volume is graphically represented as a heat map of a 3-dimensional 
reconstruction of contiguous mitochondrial surfaces identified in a series of 20–25 optical sections. Red 
corresponds to reconstructions with the largest volume, and blue to the smallest. Images from time-lapse 
videos of color-coded mitochondria indicate volume changes at times after (C) staurosporine treatment in a 
D407 cell or (D) forced HDAC3 expression in a differentiated 661W cell (see also Video 1). Note that D407 
cells have substantially smaller mitochondria than 661W cells prior to BAX recruitment. Representative graphs 
show the average (normalized) volume of mitochondria after an apoptotic stimulus within (E) a D407 cell or 
(G) a 661W cell. Each graph also depicts the average time of BAX recruitment initiation (green line) and BAX 
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the conversion of elongated to punctiform mitochondria during apoptosis16, however, has not been directly tested 
in cells lacking pro-apoptotic proteins. A principal complication hindering this analysis is that cells lacking both 
BAK and BAX have a more fragmented network of mitochondria compared to wild type counterparts due to a 
lack of fusion14,25,41. Consequently, after induction of apoptosis, there is no further decrease in mitochondrial size. 
Therefore, we implemented a system using HCT116BAX−/−/BAK−/− double knockout cells expressing either a wild 
type or a mutant BAX construct. The mutant BAX (P168A mCherry-BAX) has a proline substituted for alanine at 
amino acid 168 located at the junction between α8 and α9 (transmembrane domain) helices, and lacks the ability 
to fully recruit to the MOM42.
HCT116BAX−/−/BAK−/− cells were nucleofected with 1 µg mito-BFP and 1 µg of either mCherry, wild type 
mCherry-BAX or P168A mCherry-BAX, and 500,000 cells were plated on coverslip bottomed 35 mm tissue cul-
ture dishes. Cells were grown for three days to allow for mitochondrial dynamics to equilibrate prior to apoptosis 
induction using 1 µM STS. HCT116BAX−/−/BAK−/− cells expressing wild type or P168A mCherry-BAX showed 
elongated mitochondria three days after nucleofection, while cells expressing empty mCherry (control) exhibited 
fragmented mitochondria (Fig. S3). Mitochondrial morphology defects in cells lacking BAX and BAK, along 
with recovery of morphology after wild type BAX expression, are consistent with previous reports25. Electron 
microscopy of mitochondria in cells expressing the same three constructs confirmed that the mitochondrial 
cristae structure and integrity were intact, showing no differences between wild type and P168A BAX, or between 
cells expressing BAX constructs and control cells expressing only mCherry (Fig. 2A–F). Both wild type and 
P168A mCherry-BAX expressing cells exhibited similarly sized mitochondria, which were significantly greater in 
cross-sectional area when compared to mCherry alone (Fig. 2G, p < 0.0004).
These results suggest that conformational changes in the C-terminus of BAX are not critical for a functional 
role in fusion. This aligns with previous results from Hoppins and colleagues23 demonstrating that only the sol-
uble form of BAX participates in fusion. Both activated BAX and a tethered non-oligomerizing mutant (BAX 
1-2/L-6) fail to participate in fusion, suggesting that BAX rearranges to interact with MFN2 for fusion at the 
MOM. Since P168A BAX successfully executes fusion, it must also be shuttled to the MOM43, and interact with 
MFN2 to achieve this44,45.
After mitochondrial recovery, cells were challenged with STS to induce apoptosis. At 18 hours after induction, 
no changes in mitochondrial morphology were present in the mCherry only (control) condition, which remained 
predominantly small and fragmented (Fig. S3B). In the presence of wild type mCherry-BAX, apoptosis induction 
caused a shift from mitochondria exhibiting a connected network (Fig. S3A), to small and fragmented organelles 
(Fig. S3B). This was correlated with the recruitment of wild type mCherry-BAX to form puncta at the mito-
chondria. Importantly, in the presence of P168A mCherry-BAX, apoptosis induction did not change the mito-
chondrial morphology, as the mitochondria remained filamentous and connected, and P168A mCherry-BAX 
remained cytoplasmic (Fig. S3B).
To quantify the morphological differences observed between each condition, mitochondrial volume meas-
urements were calculated for all mitochondria within a cell. IMARIS 7.7 was used to map, in three dimensions, 
the mitochondria labeled with mito-BFP. In Fig. 2H–M, heatmap representations of the volume of mitochon-
dria within a representative cell for each condition are shown. The average volume of all mitochondria within 
a cell was calculated. Therefore, a cell with fragmented mitochondria would be represented by a small aver-
age volume per object. From three separate experiments, the average mitochondrial volume for cells expressing 
wild type mCherry-BAX before and after STS addition was 3.7 ± 0.2 µm3 (±s.e.m.) and 2.1 ± 0.1 µm3 (Fig. 2N), 
respectively, showing a statistically significant change (p < 1 × 10−7). These two measurements provide the best 
representation for a filamentous network of mitochondria in a healthy cell and the fragmented mitochondria 
that result from the fission events that occur during apoptosis. Cells expressing P168A mCherry-BAX at base-
line had an average mitochondrial volume of 3.3 ± 0.3 µm3, which was not statistically different from wild type 
mCherry-BAX at baseline (p = 0.23). After STS addition, the average mitochondrial volume for cells express-
ing P168A mCherry-BAX was 3.1 ± 0.1 µm3, which was statistically similar to baseline (p = 0.44). The average 
mitochondrial volume for cells expressing mCherry alone before and after STS induction was 1.6 ± 0.1 µm3 and 
1.9 ± 0.1 µm3, respectively, which was statistically different (p < 0.05), although not significantly different from 
cells expressing wild type mCherry-BAX after STS addition (p = 0.36). This modest volume increase is likely not 
due to mitochondrial elongation induced by mCherry, but may be attributed to condensation of organelles as 
the cell atrophies and becomes more globular after addition of STS. Since we did not correct the 3-dimensional 
data for increased point spread function in the Z-plane (by deconvolution), the compression of cells may slightly 
change the volume measurements by changing the point spread function. To corroborate this, we also analyzed 
a second metric (axial length of the mitochondria) and found that there was no significant difference between 
cells expressing mCherry alone before and after STS addition (p = 0.14, Fig. S4). The axial length measurements 
also showed the same STS-induced changes in mitochondria in cells expressing either wild type mCherry-BAX 
(a decrease in axial length) or P168A mCherry-BAX (no change in length).
recruitment completion (red line) for that specific cell. The time between each of these distinctions creates three 
stages; Stages 1, 2, and 3, identifying 20 minutes before, during and 20 minutes after BAX recruitment. (F) D407 
cells showed a Stage 1 rate of change of −0.29 ± 0.6 relative mitochondrial volume (RMV)/min, Stage 2 rate 
of 0.73 ± 1.2 RMV/min, and Stage 3 rate of −3.0 ± 1.2 RMV/min (n = 6 cells), (H) while 661W cells showed 
Stage 1 rate of change of −0.19 ± 0.8 RMV/min, Stage 2 rate of −0.50 ± 0.5 RMV/min, and Stage 3 rate of 
−1.45 ± 0.5 RMV/min (n = 4 cells). For both cell types, the rate of change of mitochondrial volume in Stage 2 
was statistically similar to Stage 1 by a two-tailed t-test (D407 p = 0.28, 661W p = 0.45). The rate of change in 
Stage 3 was significantly faster than Stage 1 (D407, 661W *p < 0.05). Size bar = 500 nm (A,B), 3 µm (C,D)
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Figure 2. The apoptotic function of BAX is required for mitochondrial fragmentation. Representative 
transmission electron microscope images of HCT116BAX−/−/BAK−/− cells expressing (A,B) mCherry, (C,D) 
wild type mCherry-BAX, or (E, F) P168A mCherry-BAX. All conditions exhibit intact double membranes 
and tubular cristae formation. (G) Mitochondrial area was calculated using ImageJ (v1.42q) on mitochondria 
exhibiting a circular cross section to eliminate sectioning bias. The average area for mCherry was 0.218 ± 0.016 
(±s.e.m.), wild type mCherry-BAX was 0.327 ± 0.025, and P168A mCherry-BAX was 0.385 ± 0.030 µm2 (n ≥ 35 
mitochondria per condition). Both wild type and P168A mCherry-BAX exhibited similar mitochondrial area 
(p = 0.134), which were each significantly greater when compared to mCherry alone (p < 0.004 and p < 0.0001, 
respectively). (A, C, E) Size bar = 1 µm. (B,D,F) Size bar = 200 nm. (H–M) Heat maps of mitochondrial volume 
are shown for representative cells, before and 18 hrs after staurosporine (STS) addition. A numerical based 
color-coded scale from 0 µm3 to 15 µm3 is shown at the bottom of the panels. Panels H and I show mCherry only 
control at 0 h and 18 hr after STS. Both conditions contain fragmented mitochondria and are primarily colored 
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We then further examined if impaired mitochondrial fission was correlated with the cell’s ability to release 
cytochrome c after STS addition. Double knock-out HCT116 cells were again nucleofected with plasmids for 
mCherry alone, wild type mCherry-BAX, or the P168A mCherry-BAX mutant, along with plasmids expressing 
mito-BFP and cytochrome c-GFP. After 24 hrs, cells exhibited diffuse BAX localization and punctate cytochrome 
c-GFP, which co-localized with mito-BFP (Fig. S5). Cells were then treated with STS and observed 18 hrs later and 
quantified for diffuse localization of cytochrome c-GFP, indicating its release from the mitochondria (Figs 2O, 
S5). Cells expressing mCherry alone exhibited no increase in cytochrome c release at 18 hrs relative to untreated 
cells, while 68 ± 6% of labeled cells expressing wild type mCherry-BAX had released cytochrome c by this point 
(p < 0.001 relative to 0 hrs). Cells expressing the P168A mCherry-BAX mutant exhibited a modest increase in the 
release of cytochrome c-GFP (23 ± 8%), but this was not a significant increase over pre-addition of STS.
These data show that P168A mCherry-BAX successfully restores mitochondrial volume to similar levels as 
wild type mCherry-BAX, creating a condition to test the dependency of BAX on apoptosis-induced mitochon-
drial fission. When inducing this condition for apoptosis, both MOMP and mitochondrial fragmentation were 
prevented as evidenced by a reduction in cytochrome c release, and the lack of mitochondrial fragmentation. 
Combined with the temporal data shown in Fig. 1, this suggests a requirement for completion of the late phase 
of BAX recruitment, rather than as a consequence of MOMP in the early phase of BAX recruitment. Since the 
P168A mutant is known to impair MOMP, we cannot exclude the possibility that BAX-mediated MOMP or its 
associated events are required to facilitate the fragmentation process. However, BAX-dependent mitochondrial 
fragmentation has been reported to occur in the absence of MOMP by overexpression of both BAX and its natural 
antagonist, BCL-X30 (although BCL-X overexpression has been reported as blocking fragmentation by others31). 
Additionally, it is unlikely that caspase activation is involved in late phase fragmentation, since mitochondrial 
fragmentation can still occur in the presence of pan-caspase inhibitors30. Further experimentation is required 
to help distinguish if early MOMP-associated events are mechanistically relevant to the fragmentation process
It is relevant to note that there are conflicting studies of how mutations at P168 affect normal BAX function. 
Early studies using the P168A mutant showed that it remained cytosolic and was not translocated to the MOM 
unless in the presence of wild type protein42,46. Our previous studies of BAX recruitment kinetics supported this 
observation, showing that the P168A mutant was recruited to the MOM, but only after wild type protein had 
reached the plateau phase of its own recruitment28. Studies using a P168V mutant suggested that this proline 
was critical to allow the membrane associating α5α6 helices of BAX to become exposed47,48, but experiments 
in molecular modeling suggested that the mutant with an alanine substitution could allow for these helices to 
interact with the MOM47, opening the possibility that the P168A mutant does retain some level of normal BAX 
activity. Consistent with this, studies involving the expression of BAX P168A in yeast cells, or interaction of 
synthetic P168A BAX with lipid vesicles or isolated mitochondria (albeit in the presence of BAK) suggest that 
this protein can interact with lipid bilayers, form oligomers, and stimulate the release of cytochrome c48,49. This 
could explain why we see a trend toward greater cytochrome c release in double-knockout HCT116 cells after 
STS exposure (Fig. 2O).
Absence or impairment of DRP1 reduces the total level of BAX recruited to mitochondria, 
but does not affect the timing of initiation or rate of BAX recruitment. DRP1 is another 
important player in mitochondrial dynamics of healthy cells. An imbalance of the mitochondrial equilibrium 
through DRP1 knockdown, or expression of dominant-negative mutants, creates a contiguous network of 
large, multi-fasciculated organelles14,16,34,50,51. During apoptosis, loss of DRP1 prevents mitochondrial fragmen-
tation16,50,52, and has been reported to delay cytochrome c release and BAX oligomerization16,17,34,53. However, 
these conclusions were reached using only static measurements. Given the lack of temporal data describing the 
on the blue end of the volume spectrum. Panels J and K show wild type mCherry-BAX at 0 h with elongated 
mitochondria in the green to red spectrum, signifying larger volumes. With STS treatment, wild type mCherry-
BAX shows mitochondrial fragmentation, exhibited by primarily blue colored objects. Panels L and M show 
P168A mCherry-BAX, which exhibits elongated mitochondria in the green to red spectrum in both conditions, 
demonstrating that P168A can rescue mitochondrial fusion in these cells (compare to H), but the process 
of mitochondrial fragmentation is impaired. Size bar = 5 µm. (N) A graph showing the mean mitochondrial 
volumes for each condition from three separate experiments (n = 30 cells per condition). For each cell analyzed, 
the average volume of all mitochondrial objects was used. The average volumes for mitochondria for each 
condition are as follows: mCherry alone (0 h) 1.6 ± 0.1 µm3 (±s.e.m.) and (18 h) 1.9 ± 0.1 µm3 (*p < 0.05), wild 
type mCherry-BAX (0 h) 3.7 ± 0.2 µm3 and (18 h) 2.1 ± 0.1 µm3 (**p < 1 × 10−7), and P168A mCherry-BAX 
(0 h) 3.3 ± 0.3 µm3 and (18 h) 3.1 ± 0.1 µm3 (p = 0.44). For mCherry (18 h) and wild type mCherry-BAX (18 h), 
(p = 0.36). For wild type mCherry-BAX (0 h) and P168A mCherry-BAX (0 h), (p = 0.23). The P168A BAX 
mutant also impairs cytochrome c release after STS addition. (O) A graph shows the percentage of total cells 
exhibiting the release of cytochrome c-GFP (based on diffuse localization in the cytoplasm, see supplemental 
Fig. S5). Each condition exhibits at least 85% of cells with cytochrome c-GFP localized to the mitochondria, 
except in wild type mCherry-BAX at 18 hours after STS addition, where the majority of cells (68%) show 
cytoplasmic localization of cytochrome c-GFP. There is no statistical difference between the percentage of cells 
that exhibit cytoplasmic cytochrome c-GFP localization at 0 and 18 hours in the mCherry condition (p = 0.93) 
or in the P168A mCherry-BAX condition (p = 0.06). There was a significant difference in the numbers of cells 
with cytoplasmic cytochrome c-GFP in the wild type mCherry-BAX condition after STS addition (*p < 0.0005). 
The total number of cells was counted from three separate experiments (n ≥ 125 cells per condition, except 
18 hours wild type mCherry-BAX where n = 87 cells).
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Figure 3. Deletion or expression of dominant negative DRP1 affects mitochondrial morphology. DRP1−/− cells, or 
expression of dominant negative mutant R247E DRP1 in wild type cells, affect the ability of mitochondria to execute 
fission. All cells were nucleofected with a plasmid carrying mito-BFP to visualize mitochondria. Mitochondrial 
morphologies are shown for (A,B) HeLa wild type (WT), (C,D) HeLaDRP1−/−, (E,F) WT HeLa + R247E DRP1, 
or (G,H) HeLaDRP1−/− + WT DRP1at (A,C,E,G) conditions prior to apoptosis induction, and (B,D,F,H) 3 h after 
addition of 1 µM staurosporine (STS), respectively. Induction of apoptosis execution was determined by presence 
of BAX puncta within the cell (not shown). Size bar = 5 µm. (I) Mitochondrial morphology was scored by a masked 
observer for a fragmented, filamentous, or a highly interconnected network-like appearance, before or after the 
addition of STS. WT cells exhibit predominantly filamentous mitochondria before STS addition, and highly 
fragmented mitochondria after (p < 0.0001, Chi Square test, n = 126 and 114 cells, respectively). DRP1−/− HeLa 
cells exhibit significantly more net-like mitochondria (p < 0.0001 relative to WT) prior to STS addition. STS 
induces a modest, but significant change in mitochondrial structure toward a fragmented appearance (p = 0.001, 
n = 144 and 123 cells, respectively). The expression of the dominant-negative R247E DRP1 mutant induces an 
intermediate phenotype for mitochondria, with a predominant mixture of filamentous and net-like structures that 
is significantly different from both WT cells (p < 0.0001) and DRP1−/− cells (p < 0.0001) prior to STS addition. The 
addition of STS promotes a shift toward fragmented mitochondria (p = 0.015, n = 81 and 81 cells, respectively). 
Expression of WT DRP1 in DRP1−/− cells reverts pre-STS mitochondrial morphology to a phenotype that is 
statistically similar to WT HeLa cells (p = 0.163), and the addition of STS is accompanied by a significant increase 
in mitochondrial fragmentation (p < 0.0001, n = 99 and 90 cells, respectively), that is even more pronounced than 
in WT cells (p < 0.001). (J) In a different set of experiments, we also examined the effect of DRP1 deficiency on the 
release of cytochrome c. Cells of the four different groups were nucleofected with cytochrome c-GFP, treated with 
STS, and then scored for cytosolic or mitochondrial cytochrome c-GFP. The graph shows the percentage of scored 
cells (mean ± s.e.m.) that exhibit the release of cytochrome c, 3 h after STS addition. Consistent with other reports, 
DRP1−/− cells exhibit retarded release of cytochrome c relative to both WT cells (*p < 0.01, t-test) or DRP1−/− cells 
expressing a WT DRP1 construct (**p < 0.0002). WT cells expressing the R247E mutant have an intermediate 
phenotype that is statistically similar to both WT and DRP1−/− cells (p = 0.693 and 0.095, respectively), similar to 
the mitochondrial morphology phenotype. Total cells scored, n = 232 (WT), 215 (DRP1−/−), 136 (WT cells + R247E 
DRP1), and 122 (DRP1−/− cells + WT DRP1).
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influence of DRP1 on BAX recruitment and mitochondrial remodeling, we next evaluated the kinetics of BAX 
recruitment as a function of wild type, ablated or impaired DRP1 activity. For these experiments, we used HeLa 
cells, which either had been engineered to be deficient for DRP1 (HeLaDRP1−/−) or were expressing the R247E 
dominant negative mutant for DRP134. Both conditions showed significantly greater percentages of cells exhib-
iting a hyperfused mitochondrial network when compared to wild type HeLa cells or HeLaDRP1−/− cells that had 
been rescued by nucleofection with a plasmid containing wild type DRP1 (Fig. 3A–H). We then evaluated if 
the hyperfused network of mitochondria in HeLaDRP1−/− cells or wild type HeLa cells expressing R247E DRP1 
was maintained after 3 hours STS treatment. While STS did induce a significant redistribution of mitochondrial 
morphology in these cells, including an increase in the number of cells with fragmented mitochondria (relative to 
pre-STS treatment, p = 0.001 and 0.015, respectively), both wild type and rescued HeLa cells exhibited a substan-
tially greater increase in fragmentation under these conditions (Fig. 3I, p < 0.0001). Assessment of cytochrome 
Figure 4. Deletion or expression of dominant negative DRP1 affects total BAX recruitment. Box and whisker 
plots show the (A) BAX recruitment initiation time (from staurosporine addition) and (B) rate of BAX 
recruitment. There were no significant differences among all conditions for either the initiation or rate of BAX 
recruitment (p = 0.75, p = 1.0, respectively, by one-way ANOVA.) (C) BAX recruitment sigmoid curves defined 
by median optimal parameters for each set of BAX recruitment curves was plotted for each condition (see 
Fig. S7 for complete set of curves). The median plateau value (Y-max) for BAX recruitment is reduced by 25% 
in cells lacking DRP1 and 20% in cells expressing the R247E DRP1 dominant-negative mutant, respectively. 
(D) Box and whisker plot of Y-max values reveal that HeLa wild type cells and HeLaDRP1−/− cells expressing 
exogenous WT DRP1 have significantly less BAX recruited than HeLaDRP1−/− cells and HeLa cells expressing 
R247E DRP1 (**p < 0.01).
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c release showed that among four DRP1 conditions, only HeLaDRP1−/− cells showed a significant reduction in the 
percentage of cells with cytochrome c release at this timepoint (Fig. 3J, p = 0.01 and 0.0001, relative to wild type 
and rescued cells, respectively). HeLa cells expressing the R247E dominant negative mutant represented what 
could be considered an intermediate phenotype, being not statistically different from either wild type, rescued, or 
DRP1−/− cells. Collectively, these data are consistent with the observations of other groups showing both delayed 
MOMP and fission in DRP1-impaired cells17,34,50,53. When we examined the kinetics of BAX recruitment in cells 
with impaired DRP1 function, however, we observed that neither the average time of initiation, nor the average 
rate of BAX recruitment was affected in either HeLaDRP1−/− cells, or wild type HeLa cells expressing the R247E 
DRP1 mutant, when compared to wild type cells or rescued HeLaDRP1−/− cells (Fig. 4A,B). DRP1-deficiency also 
had no apparent effect on the activation of recruited endogenous BAX, which could be stained positive using the 
6A7 monoclonal antibody (Fig. S6A–D). We did observe, however, a significant reduction in the total level of BAX 
recruited to the MOM in kinetic analysis of cells with absent or impaired DRP1. Figure 4C shows the median 
recruitment curves of all the mitochondrial foci examined in each condition (see Fig. S7 for complete datasets), 
and Fig. 4D shows a graphical representation of the combined data on final recruitment levels. HeLaDRP1−/− cells 
exhibited 25% less BAX recruitment and R247E DRP1 expressing cells showed 20% less recruited BAX (p < 0.01 
and p < 0.001, respectively compared to wild type HeLa cells). The decrease in total BAX recruitment could be 
completely rescued in HeLaDRP1−/− cells expressing an exogenous wild type DRP1 construct (p = 0.84, compared 
to wild type cells). This data was corroborated in static experiments assessing the level of staining intensity for 
the endogenous BAX 6A7 antigen in DRP1−/− HeLa cells, which showed a 25.6% reduction in activated BAX 
per punctum on average and a reduction in the average number of BAX foci formed, relative to wild type cells 
(Fig. S6E,F). This was not caused by a reduction in the overall amount of BAX being expressed in HeLaDRP1−/− 
cells (Fig. S6G,H).
These results align with reports that the membrane tethering activity of DRP1 acts to promote BAX oligomer-
ization34, but show that DRP1 is not required for the initial MOM recruitment or activation of BAX during 
apoptosis. We speculate that initiation of the MOMP activity of BAX is independent of the function of DRP1, but 
that DRP1 facilitates further accumulation of BAX in a later phase of recruitment. Consistent with this concept, 
DRP1 is not required for the release of SMAC/Diablo, another mitochondrial protein that requires BAX permea-
bilization of the mitochondrial membrane52,54,55, while the impaired release of cytochrome c may be more related 
to the effect of DRP1 on cardiolipin transfer from the mitochondrial inner membrane to the MOM56. Further 
accumulation of BAX, mediated by DRP1, may contribute to so-called “non-random BAX structures”57, which 
have been described as BAX-containing lines, arcs, and rings in studies using super resolution microscopy. The 
formation of these non-random structures is reduced in DRP1-deficient cells54, which correlates with a delay in 
cytochrome c release. Conversely, there is clearly an intrinsic ability of BAX to form “arcs and rings”, since sim-
ilar ring structures are formed by purified BAX (in the presence of tBID) in cardiolipin-containing liposomes58. 
Probably more relevant, however, is that non-random BAX structures underlie the formation of macropores 
necessary for mitochondrial inner membrane herniations and the release of mtDNA38.
While a great deal of speculation has been posited regarding the formation of non-random BAX structures 
and their role as pores in the MOM, the focus of this study was to evaluate BAX function as a vital component 
in the process of mitochondrial fission. Careful quantification of BAX containing structures by Salvador-Gallego 
and colleagues revealed that non-random structures represented only a small percentage of the total BAX that 
had accumulated at the MOM57. A majority of BAX formed small “dots” or large aggregates. Aggregates were 
observed to often form at discrete locations on mitochondrial tubules, or were identified at the tips of mitochon-
drial fragments54,57, possibly at a site of a recent fission event, such as described by Karbowski and colleagues31, 
and demonstrated in Fig. 1. Similarly, non-random BAX structures may also participate in fission events. Große 
and colleagues54 rarely observed rings, and then only small ones, on elongated mitochondria, but often found 
rings associated with mitochondrial fragments. BAX-containing lines were also described as “wrapping” around 
mitochondria by Salvador-Gallego and colleagues57. Given such observations, it is not difficult to envision a 
model where larger BAX assemblies could help perforate a mitochondrion to weaken membrane integrity, allow-
ing other members of the fission machinery to more efficiently complete the process (Fig. 5). We speculate that 
the construction of these assemblies is mediated by DRP1. This concept is consistent with results obtained in 
protozoan studies using T. brucei. Fission of the single giant mitochondrion in this organism is stimulated when 
an exogenous BAX protein is introduced, but only in the presence of the endogenous dynamin-like protein36,59.
In addition to DRP1, DYN2 is also necessary to execute the process of mitochondrial fission17. In vitro studies 
have shown that while DRP1 can tubulate membranes, it has no intrinsic ability to complete scission of them60. 
Alternatively, this ability is intrinsic to classical dynamin proteins61. Kinetic studies show accumulation of DRP1 
prior to DYN2 at mitochondrial fission sites, suggesting that DRP1 may facilitate recruitment of DYN2 to these 
regions, similar to the mechanism we are proposing for BAX aggregation. Loss of DYN2 expression exerts sim-
ilar effects as loss of DRP1, such as elongated mitochondria in living cells and a delayed onset of apoptosis. 
Knockdown of DRP1 or DYN2 with siRNA reduced the level of cytochrome c release when compared to control 
after 1.5 hours of STS treatment, but the same conditions showed accelerated BAX activation compared to con-
trol17 when assessed by exposure of the 6A7 antibody epitope. These data, which show that BAX recruitment and 
activation are not strictly reliant on DRP1, are consistent with our findings that BAX recruitment initiates at the 
same time after STS addition in wild type and DRP1-deficient cells HeLa cells (Fig. 4B).
In summary, we directly tested the requirement of BAX in the apoptosis-associated fission process by using 
the P168A BAX mutant, to first recover mitochondrial morphology, then to show lack of mitochondrial fragmen-
tation after apoptosis induction. In kinetic studies we show that the completion of BAX recruitment identifies the 
timeframe for the start of rapid mitochondrial fragmentation, a phase of BAX recruitment that previously had no 
defined role. Additionally, this phase of BAX recruitment is affected by the loss or mutation of DRP1, suggesting 
a cooperative role in the rapid mitochondrial fragmentation process during apoptosis, consistent with a model 
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originally proposed by Martinou and Youle29 where BAX may perforate the MOM through the formation of 
hemifusion intermediates to facilitate the fragmentation. Our prediction is that BAX oligomerization has an early 
phase, creating micropores leading to MOMP, an intermediate phase creating macropores leading to the release 
of larger mitochondrial components (such as evulsions of the inner membrane), and a late phase facilitated by 
DRP1, that is associated with mitochondrial fragmentation. Ultimately, identifying BAX mutants that can distin-
guish between these phases is a necessary step in confirming this model.
Figure 5. Proposed model for BAX participation in mitochondrial fission during apoptosis. (A–C) Initiation of 
BAX recruitment (Stage 1) is comprised of BAX integration into the MOM, MOMP and cytochrome c release. 
At this stage, (A) the time to initiate BAX recruitment is indistinguishable between wild type and DRP1−/− cells. 
In wild type cells, DRP1 has already recruited to the MOM. (B,C) Cytochrome c is released in both cell types, 
however DRP1−/− cells show a reduction in the percentage of cells releasing cytochrome c. This difference 
may be related to a proposed function of DRP1 in facilitating transfer of cardiolipin, which is associated with 
cytochrome c, from the inner membrane to the MOM51. The release of other molecules, such as SMAC, is not 
inhibited in DRP1−/− cells48–50. BAX dimers and/or small oligomers are present at this stage. We define BAX 
structures at this stage as micropores. (D–F) The exponential phase of BAX recruitment (Stage 2) is defined 
as the period of BAX accumulation at the MOM. (D) The rate of BAX recruitment does not differ between 
wild type and DRP1−/− cells. (E) At the site of DRP1 constriction of the mitochondria in wild type cells, BAX 
accumulation takes on higher order non-random structures, however (F) these structures lack organized 
localization at the scission site in the absence of DRP1. We define these BAX structures as macropore oligomers, 
and may be required for the release of larger molecules and/or evulsions of the mitochondrial inner membrane. 
(G–I) Completion of BAX recruitment (Stage 3) is identified as the point where the (G) BAX recruitment curve 
plateaus. (H) Importantly, this turning point is accompanied by mitochondrial fragmentation in wild type cells. 
DRP1-mediated recruitment of BAX to the mitochondrial scission sites allows for non-random BAX structures 
or rings that are organized to completely encircle the mitochondrion. This likely weakens membrane integrity 
through presence of many adjacent macropores, creating a perforated membrane, and allowing constriction 
pressure created by DRP1 and its assemblies to complete the membrane separation. We define these BAX 
structures as fission oligomers. This model, where BAX perforates the membrane, is consistent with a model 
originally proposed by Martinou and Youle29. (I) Conversely, BAX structures on DRP1-deficient mitochondria 
are unable to organize around DRP1 identified scission sites, therefore cannot provide a perforated region to 
facilitate mitochondrial fragmentation. Loss or impairment of DRP1 function also results in fewer BAX puncta 
that contain approximately 25% less BAX protein. Therefore, DRP1-mediated fission oligomers may evolve 
both by coalescence of macropore oligomers and late-stage recruitment of inactive latent BAX monomers. For 
example, P168A mutant BAX cannot normally recruit to the MOM in apoptotic cells, unless in the presence of 
wild type BAX protein42. Kinetic studies indicate that this recruitment process occurs only after wild type BAX 
nears the plateau phase of its recruitment28, when we predict that fission oligomers are being formed.
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Materials and Methods
tissue culture cells and nucleofection. All tissue culture cells were maintained at 37 °C and 5% CO2. 
D407 cells (immortalized human retinal pigment epithelial cells), 661W cells (differentiated mouse neu-
ron progenitor cells) and HeLa cells (immortalized human cervical cancer cells) were cultured in DMEM 
(Cellgro, Mediatech, Inc., Manassas, VA) supplemented with 1% Antibiotic/Antimycotic (Cellgro, Mediatech, 
Inc., Manassas, VA) and 3% (D407) or 10% (661W, HeLa) Fetal Bovine Serum (Atlanta Biologicals, Norcross, 
GA). 661W cells were differentiated into a neuron-like phenotype by treatment with 316 nM staurosporine for 
24 hours. HCT116 cells (immortalized human colorectal cancer cells) were cultured in McCoy’s 5A medium 
(Lonza, Basel, Switzerland) supplemented with 10% FBS (Cellgro) and 1% Antibiotic/Antimycotic (Cellgro). 
ARPE-19 cells (immortalized human retinal pigment epithelial cells) were cultured in DMEM:F12 (Hyclone, GE 
Healthcare Life Sciences, Marlborough, MA), supplemented with 10% Fetal Bovine Serum (Atlanta Biologicals) 
and 1% Antibiotic/Antimycotic (Cellgro). 1 μg of each plasmid DNA was used for each nucleofection reaction 
(Amaxa Nucleofector, Lonza, Basel, Switzerland), which was comprised of one million cells unless otherwise 
noted. D407, ARPE-19, HeLa, and HCT116 cells were induced for apoptosis using a final concentration of 1 µM 
staurosporine (Sigma, St. Louis, MO) prepared in DMSO, while overexpression of Flag-HDAC3 was used to 
induce apoptosis in 661W cells (Addgene, Cambridge, MA, plasmid #13819), a gift from Eric Verdin. HDAC3 is 
selectively toxic to differentiated neurons62.
D407 and ARPE-19 cells were a gift from Dr. Aparna Lakkaraju. The D407 cells originated from Dr. R. Hunt 
at the University of South Carolina. HCT116BAX−/−/BAK−/− cells and HeLaDRP1−/− cells were a gift from Dr. Richard 
Youle41. Experiments introducing BAX mutant DNA, which prevented cytochrome c release after STS treatment, 
provided evidence of authenticity for HCT116BAX−/−/BAK−/− cells. HeLaDRP1−/− cells stocks were authenticated in 
Dr. Youle’s laboratory prior to receipt. 661W cells were a gift from Dr. Leonard Levin and have been confirmed in 
our laboratory as Mus musculus origin by PCR of the mitochondria d-loop63, and their ability to differentiate into 
a neuron-like phenotype after exposure to 316 nM STS by extending neurite like processes and the up-regulation 
of neuronal markers64.
Immunostaining for activated BAX. Three hours after the addition of 1μM staurosporine, wild type 
and DRP1−/− HeLa cells were fixed in 4% paraformaldehyde in phosphate buffered saline (PBS) for 8 minutes 
at room temperature. Cells were then washed three times in PBS for five minutes before blocking in 10% horse 
serum and 0.3% Triton X-100 in PBS for 1 hour at room temperature. After washing three times in PBS for five 
minutes, cells were incubated in 5% horse serum with 0.1% Triton X-100 and 1:200 anti-BAX (6A7) mouse 
monoclonal antibody (catalog #sc-23959, Santa Cruz Biotechnology, Santa Cruz, CA) for 24 hours at 4 °C. Cells 
were again washed and incubated in 5% horse serum and 0.1% Triton X-100 containing 1:1000 Alexa Fluor 
488-congugated AffiniPure goat anti-mouse antibody (catalog #115-545-003, Jackson ImmunoResearch, West 
Grove, PA) for 2 hours at room temperature. Slides were then washed with PBS and mounted with Immunomount 
(ThermoFisher Scientific, Waltham, MA).
Slides were imaged using a Zeiss Axioplan 2 Imaging microscope with Axiovision 4.6.3.0 software (Carl Zeiss 
MicroImaging Inc., Dublin, CA). All images were obtained using a 63X oil objective with the same laser intensity 
(50%) and exposure time (500 ms). Fluorescence intensity was measured using ZEN 2.3 (blue edition) imaging 
software (Carl Zeiss MicroImaging, Inc.). Twenty puncta from each cell (n = 5 per group) were outlined as well 
as twenty spots from the background of the image. The average intensity of the background of each image was 
subtracted from the intensity of each puncta.
Western blotting. HeLa wild type and DRP1−/− cells were washed with PBS, pelleted, and frozen at −80 °C. 
Cell pellets were resuspended in 200 µl of RIPA buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 5 mM EDTA, 1.0% 
IGEPAL, 0.5% Na Deoxycholate, 0.1% SDS) containing 0.1% PMSF and sonicated. Protein levels were quanti-
fied using the Pierce bicinchoninin acid assay (BCA, ThermoFisher Scientific) and 20, 30, and 50 µg of protein 
from each cell pellet was combined with 2x Laemmli buffer (125 mM Tris, pH 6.8, 4% SDS, 10% glycerol, 10% 
β-mercaptoethanol, 0.004% bromphenol blue), heated for 5 min at 70 °C, and run on 12% polyacrylamide SDS 
gels. After electrophoresis, proteins were electroblotted onto Immobilon-FL PVDF transfer membrane (EMD 
Millipore, ThermoFisher Scientific). Total protein loads were measured by staining the membranes with Revert 
700 total protein stain (LI-COR, Lincoln, NB) and imaged using a LI-COR Odyssey CLX scanner at 700 nm. 
Transfer membranes were then blocked in PBS containing 0.1% Tween-20 (PBST) and 5% powdered milk for 
2 hours at 22 °C. BAX was detected by incubating the membrane in PBST containing a rabbit polyclonal anti-
body against BAX (#B3428, 1:500 dilution, Sigma) overnight at 4 °C. This antibody was previously confirmed 
to be BAX-specific by the absence of a signal in tissue extracts from Bax-deficient mice compared to wild type 
tissues65. After washing in PBST, the blots were then incubated in PBST with 5% milk containing goat anti-rabbit 
IgG conjugated to IRDye800CW (#926-32211, 1:5000 dilution, LI-COR) for 2 hours at 26 °C. Membranes were 
then washed in PBST and imaged on the Odyssey CLX scanner at 800 nm. For quantification, LI-COR scans were 
converted to greyscale and pixel density was measured using ImageJ (v1.42q). To normalized BAX levels, the 
pixel level of BAX was divided by the pixel value for total protein in each lane, for each different concentration of 
protein loaded. Relative values for all 3 measurements for two separate cell pellets of each genotype were graphed 
and used for statistical analysis.
plasmids. GFP-BAX, mCherry-BAX, the transmembrane mutant mCherry-BAXP168A, and mito-BFP were 
cloned in the lab as previously described28,66. The vector backbone for these plasmids include peGFP-C3 and 
pmCherry-C1 (Clontech, Mountainview, CA) and TagBFP-N (Evrogen, Moscow, Russia). All transgenes were 
expressed from the CMV immediate early promoter. Cytochrome c-GFP (Addgene, plasmid #41182) was a gift 
from Douglas Green67. mCherry-DRP1 (Addgene, plasmid #49152) was a gift from Dr. Gia Voeltz68 and was 
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used to generate the DRP1 mutant (R247E mCherry-DRP1) construct using the QuikChange II site-directed 
mutagenesis protocol (Agilent Technologies, Santa Clara, CA) to mutate arginine 247 to glutamic acid, which was 
verified by sequencing.
Image acquisition and analysis. Live-cell and static imaging was performed using the Andor Revolution 
XD spinning disc confocal microscopy system (Andor, Belfast, Northern Ireland) comprised of the Nikon Eclipse 
Ti inverted microscope, Nikon objectives, the iXon x3 897 EM-CCD camera, a Yokogawa CSU-X1 confocal spin-
ning disk head, the Andor Laser Combiner with four solid state lasers, an ASI motorized stage with Piezo-Z, and 
an Okolab CO2 cage incubator for temperature and CO2 control at 37 °C and 5% CO2. For time-lapse imaging, 
cells were plated at a density of 100,000–300,000 cells per well on 4-well chamber slides containing #1.5 optical 
grade plastic (Ibidi, Madison, WI). Live-cell treatments were staggered for an appropriate time for the cell type to 
ensure the ability to image each well on a slide. Prior to imaging, phenol-containing media was removed from the 
well, and replaced with a house made ‘recording media’ (HBSS with 1.26 mM calcium chloride, 0.49 mM magne-
sium chloride, 0.4 mM magnesium sulfate, no phenol red, 4.5 g/L glucose and 10 mM Hepes) supplemented with 
appropriate serum concentration. Under temperature and CO2 control, time-lapse imaging was performed using 
a 100X oil objective (numerical aperture = 1.49, temperature collar for 23 °C to 37 °C) by collecting z-stacks con-
sisting of 20–25 optical sections at 0.22 µm (Nyquist) taken every minute for one to two hours. All imaging was 
performed under the same laser intensity, electron-multiplying gain and exposure time. All time-lapse images 
were subject to the same background subtraction and Gaussian filter within the IMARIS 7.7 software (Bitplane, 
Concord, MA), where each filter has its own constant algorithm and threshold setting. ARPE-19 cells were ana-
lyzed with IMARIS 9.2.1 under the same conditions.
From each cell captured using time-lapse live-imaging, BAX recruitment was analyzed as described below. 
A more detailed description is available in a previous publication28. First, isolated mitochondria organelles were 
identified based on mito-BFP label using the ‘spots’ function in IMARIS. From each spot, the fluorescence inten-
sity of tagged-BAX was collected over the duration of the time-lapse image. Fluorescence curves from several 
spots were collected for each cell. All fluorescence intensity curves were normalized to their own baseline fluores-
cence intensity to allow for comparison among curves. Next, a sigmoid curve was fit to the normalized fluores-
cence data using the modified sigmoid equation below (Eq. 1). Parameters (a, b, k, x0, y0) were tested to find the 









This best fit curve was defined as a BAX recruitment curve, which contained optimal parameters 
(a b k x y, , , ,0 0) from which several metrics for analysis could be derived. First, the rate of BAX recruitment was 
defined as the maximum rate of the sigmoid curve. BAX recruitment initiation was defined from the 5% thresh-
old value, which is where the slope of a line (derived the maximum rate of the sigmoid curve) intersects the min-
imum boundary of the sigmoid curve. (See Fig. S1). For compiled BAX recruitment curves, the optimal 
parameters were collected for each sigmoid curve from the population of mitochondria for each condition. The 
median optimal parameters for each treatment group was used to plot a single, representative sigmoid curve.
Mitochondrial volume measurements were obtained from the “surfaces” function in IMARIS. In time-lapse 
volume measurements, the mito-BFP channel was normalized using the ‘Normalize time points’ Xtension in 
IMARIS to correct for photobleaching throughout the duration of the time-lapse video. For static volume meas-
urements, the IMARIS-defined “surfaces” encompassing mitochondria were manually edited on a per cell basis 
to acquire precise volume measurements, rather than using a threshold approach as in time-lapse image analysis, 
which allows for comparison among timepoints. All images within a single figure were prepared using the same 
brightness, contrast and color adjustments in Photoshop. To allow for best visualization, cells of interest were 
cropped from original image files containing multiple cells and placed on a black background.
Electron Microscopy. HCT116 cells were grown on round coverslips in a 12-well tissue culture dish. Cells 
were prepared using a protocol optimized to preserve mitochondrial structure similar to the protocol used by 
Kim and colleagues69. Briefly, cells were fixed in 2% paraformaldehyde and 2.5% glutaraldehyde in 0.1 M caco-
dylate buffer for 5 min at room temperature, then continued fixation for 30 minutes on ice. The wash buffer, 
post-fix, water and uranyl acetate for the following steps were kept ice-cold to allow for optimal mitochondrial 
preservation. A wash buffer containing 0.1 M sodium cacodylate and 3 mM calcium chloride was used for a 
series of 5 washes. Washes were followed by a 30 minute post-fixation on ice. The post-fix was comprised of 1% 
osmium tetroxide, 0.8% potassium ferrocyanide, and 3 mM calcium chloride. The cells were then washed with 
distilled water and stained with 2% uranyl acetate overnight. The following day, cells were dehydrated, infiltrated 
and embedded in Epon epoxy and sectioned at 60–90 nm. Sections were imaged on a Phillips CM120 transmis-
sion electron microscope (FEI Co., Hillsboro, OR). Measurements of mitochondrial area were taken from round 
sections, since we interpreted these as being truer to cross-sectional area and reduced bias from longitudinal 
sections. Area was measured using ImageJ (v1.42q).
Mitochondrial network categorization. Net-like mitochondria were classified as those exhibiting near 
complete connectivity of the mitochondrial network, often with bulbous protrusions at intersections of several 
filamentous regions. Mitochondria networks classified as filamentous were identified by their more elongated 
structure, but with clear separation among groupings of filamentous structures. Sometimes these cells contained 
smaller organelles. Fragmented mitochondria networks were identified by their more dotted or rice-shaped orga-
nelle appearance, with few if any elongated spaghetti-like structures.
13Scientific RepoRtS |         (2019) 9:16565  | https://doi.org/10.1038/s41598-019-53049-w
www.nature.com/scientificreportswww.nature.com/scientificreports/
Statistical analysis. Time-lapse mitochondria volume measurements were compared based on the average 
normalized volume for 20 minutes before BAX initiation, during the recruitment phase, and 20 minutes after 
BAX recruitment completion. The average normalized volumes from each phase were compared using two-tailed 
student t-test. For mitochondria volume comparisons, fragmentation, and cytochrome c release comparisons, 
percentages of total cells from three independent experiments were tested using two-tailed student t-test. For 
calculated statistics based per cell, the standard deviation was calculated for an individual cell and expressed as a 
percentage of the mean. For analysis of mitochondrial morphology in DRP1-deficient cells, the different propor-
tions of fragmented, filamentous, and net-like mitochondria were compared between groups using a Chi square 
test. Significant differences were set at a p value < 0.05. Comparisons of BAX recruitment rates and initiation 
times among the four conditions in Fig. 4 were calculated using a one-way ANOVA.
Data availability
The datasets generated during and analyzed during the current study are available from the corresponding 
author on reasonable request. Detailed methods for BAX recruitment analysis can be referenced in a previous 
publication28 and corresponding python scripts are available in the public repository (https://github.com/
maggiemaes/Methods-for-BAX-recruitment-analysis).
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